Overview

• The Strasbourg tribunal ruled on May 14, 2025, that CPAM du Bas-Rhin must fully fund a trans man’s bilateral mastectomy, overturning its earlier partial refusal.
• The court also ordered CPAM to pay €3,000 in damages, recognizing the insurer’s actions as discriminatory and a violation of privacy rights under European human rights law.
• The plaintiff, who began his transition in 2017 and started hormone therapy in 2022, faced systemic barriers, including a lengthy appeals process and outdated medical protocols cited by CPAM.
• This decision is the first in France to explicitly label such refusals as discriminatory, potentially setting a precedent for eight similar lawsuits against regional insurers currently pending.
• Advocacy groups and legal experts see the ruling as a step toward ensuring equitable access to gender-affirming care under France’s healthcare system.